FDA Inspection 1130374 — Arifulla Khan MD
The FDA completed an inspection of Arifulla Khan MD on August 31, 2020 in Bellevue, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 31, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bellevue, WA (United States)